Cartesian Therapeutics, Inc. (RNAC)
Nasdaq: RNAC · CIK 0001453687 · United States
Every official Cartesian Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RNAC filings
Cartesian Therapeutics, Inc. documents
- Cartesian Therapeutics, Inc. 10-K 2026RNAC 10-K 2026: annual report for fiscal 2026
- Cartesian Therapeutics, Inc. 10-K 2025RNAC 10-K 2025: annual report for fiscal 2025
- Cartesian Therapeutics, Inc. 10-K 2024RNAC 10-K 2024: annual report for fiscal 2024
- Cartesian Therapeutics, Inc. 10-K 2023RNAC 10-K 2023: annual report for fiscal 2023
- Cartesian Therapeutics, Inc. 10-K 2022RNAC 10-K 2022: annual report for fiscal 2022
- Cartesian Therapeutics, Inc. 10-Q 2026RNAC 10-Q 2026: quarterly report for fiscal 2026
- Cartesian Therapeutics, Inc. 10-Q 2025RNAC 10-Q 2025: quarterly report for fiscal 2025
- Cartesian Therapeutics, Inc. 10-Q 2024RNAC 10-Q 2024: quarterly report for fiscal 2024
- Cartesian Therapeutics, Inc. 10-Q 2023RNAC 10-Q 2023: quarterly report for fiscal 2023
- Cartesian Therapeutics, Inc. 10-Q 2022RNAC 10-Q 2022: quarterly report for fiscal 2022
- Cartesian Therapeutics, Inc. 8-K 2026RNAC 8-K 2026: current report for fiscal 2026
- Cartesian Therapeutics, Inc. 8-K 2025RNAC 8-K 2025: current report for fiscal 2025
- Cartesian Therapeutics, Inc. 8-K 2024RNAC 8-K 2024: current report for fiscal 2024
- Cartesian Therapeutics, Inc. 8-K 2023RNAC 8-K 2023: current report for fiscal 2023
- Cartesian Therapeutics, Inc. 8-K 2022RNAC 8-K 2022: current report for fiscal 2022
- Cartesian Therapeutics, Inc. DEF 14A 2026RNAC DEF 14A 2026: proxy statement for fiscal 2026
- Cartesian Therapeutics, Inc. DEF 14A 2025RNAC DEF 14A 2025: proxy statement for fiscal 2025
- Cartesian Therapeutics, Inc. DEF 14A 2024RNAC DEF 14A 2024: proxy statement for fiscal 2024
- Cartesian Therapeutics, Inc. DEF 14A 2023RNAC DEF 14A 2023: proxy statement for fiscal 2023
- Cartesian Therapeutics, Inc. DEF 14A 2022RNAC DEF 14A 2022: proxy statement for fiscal 2022
- Cartesian Therapeutics, Inc. Form 4 2026RNAC Form 4 2026: insider trading filing for fiscal 2026
- Cartesian Therapeutics, Inc. Form 4 2025RNAC Form 4 2025: insider trading filing for fiscal 2025
- Cartesian Therapeutics, Inc. Form 4 2024RNAC Form 4 2024: insider trading filing for fiscal 2024
- Cartesian Therapeutics, Inc. Form 4 2023RNAC Form 4 2023: insider trading filing for fiscal 2023
- Cartesian Therapeutics, Inc. Form 4 2022RNAC Form 4 2022: insider trading filing for fiscal 2022
- Cartesian Therapeutics, Inc. S-1 2026RNAC S-1 2026: registration statement for fiscal 2026
- Cartesian Therapeutics, Inc. S-1 2025RNAC S-1 2025: registration statement for fiscal 2025
- Cartesian Therapeutics, Inc. S-1 2024RNAC S-1 2024: registration statement for fiscal 2024
- Cartesian Therapeutics, Inc. S-1 2023RNAC S-1 2023: registration statement for fiscal 2023
- Cartesian Therapeutics, Inc. S-1 2022RNAC S-1 2022: registration statement for fiscal 2022
- Cartesian Therapeutics, Inc. 13F 2026RNAC 13F 2026: institutional holdings for fiscal 2026
- Cartesian Therapeutics, Inc. 13F 2025RNAC 13F 2025: institutional holdings for fiscal 2025
- Cartesian Therapeutics, Inc. 13F 2024RNAC 13F 2024: institutional holdings for fiscal 2024
- Cartesian Therapeutics, Inc. 13F 2023RNAC 13F 2023: institutional holdings for fiscal 2023
- Cartesian Therapeutics, Inc. 13F 2022RNAC 13F 2022: institutional holdings for fiscal 2022
More companies